Cormorant Pharmaceuticals AB

ABActive

Org 5568213853Solnavägen 3 H, 113 63 StockholmResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2010 · 15 years old0 employees

Overview Financials People & ownership Related companies

Cormorant Pharmaceuticals AB is a Swedish AB based in Stockholm, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2010, the company has 0 employees and reported revenue of SEK 0 in its latest annual filing.

Revenue 2024

SEK 0

EBITDA margin

—

Net profit 2024

SEK 430K

-64% vs 2023

Key ratios

See full ratios →

94.5%

This company

20202024

18.1×

This company

20202024

4.3%

This company

20202024

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 0	—
EBITDA	SEK -786K	-79%
Net profit	SEK 430K	-64%
Total assets	SEK 10,1M	-82%
Equity	SEK 9,5M	-83%
Employees	0	—

Contact

Address

Solnavägen 3 H, 113 63 Stockholm

Phone

+46733590551

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Cormorant Pharmaceuticals AB?

Cormorant Pharmaceuticals AB is registered with Bolagsverket / SCB under Org 5568213853.

Where is Cormorant Pharmaceuticals AB headquartered?

Cormorant Pharmaceuticals AB's registered address is Solnavägen 3 H.

Cormorant Pharmaceuticals AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Cormorant Pharmaceuticals AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Cormorant Pharmaceuticals AB